A REVIEW OF CURRENT STEREOTACTIC ABLATIVE RADIOTHERAPY CLINICAL TRIALS FOR OLIGOMETASTATIC CANCERS

被引：0
|
作者：
Arifin, Andrew [1 ]
Al-Shafa, Faiez [1 ]
Rodrigues, George B. [1 ]
Palma, David A. [1 ]
Louie, Alexander V. [2 ]
机构：
[1] Western Univ, London, ON, Canada
[2] Univ Toronto, Toronto, ON, Canada
来源：
RADIOTHERAPY AND ONCOLOGY | 2019年 / 139卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
98
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [41] Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults
    Chandy, E.
    Taylor, H.
    Gaito, S.
    Wells, E.
    Jones, C.
    Meehan, C.
    Burland, H.
    Stone, J.
    Snowball, C.
    Mashru, J.
    Riddell, C.
    Hon, Y.
    Welsh, L.
    Saran, F.
    Mandeville, H.
    CLINICAL ONCOLOGY, 2020, 32 (05) : 316 - 326
  • [42] Hypofractionated Stereotactic Ablative Radiotherapy for Recurrent or Oligometastatic Tumours in Children and Young Adults
    Chandy, E.
    Taylor, H.
    Gaito, S.
    Wells, E.
    Jones, C.
    Meehan, C.
    Burland, H.
    Stone, J.
    Snowball, C.
    Mashru, J.
    Riddell, C.
    Welsh, L.
    Saran, F.
    Mandeville, H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S128 - S128
  • [43] Stereotactic ablative body radiotherapy (SABR) for NSCLC oligometastatic patients: feasibility and outcomes
    Campisi, M. C.
    Navarria, P.
    Ascolese, A. M.
    De Rose, F.
    Alloisio, M.
    Infante, M.
    Palumbo, V.
    Reggiori, G.
    Tomatis, S.
    Scorsetti, M.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S119 - S119
  • [44] The what, when and how of stereotactic ablative body radiotherapy for oligometastatic prostate cancer
    Dreosti, Marcus
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 71 - 71
  • [45] Stereotactic Ablative Radiotherapy Outcomes for Bone-Only Oligometastatic Breast Cancer
    Yilmaz, Melek Tugce
    Gultekin, Melis
    Sari, Sezin Yuce
    Kumru, Tolunay
    Kivanc, Huseyin
    Ozyigit, Gokhan
    Yildiz, Ferah
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S464 - S466
  • [46] VMAT Stereotactic Ablative Radiotherapy for oligometastatic patients: role of FDG PET/CT
    BORGHES, S., I
    Gasperi, C.
    Terziani, F.
    Curion, A. S.
    Rampini, A.
    Pernici, P.
    Bertocci, S.
    Gennari, P. G.
    Iermano, C.
    De Majo, R.
    Losardo, P. L.
    Tucci, E.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1227 - S1228
  • [47] Stereotactic Ablative Radiotherapy in Oligometastatic Pulmonary Disease. First Institutional Experience
    Palacios, Ariel Gomez
    Rios, Cecilia
    Raiden, Belen
    Zelada, Crista
    Rivas, Iara
    Fernandez, Diego
    Caussa, Lucas
    Conci, Ofelia Perez
    Vazquez, Maria Fernanda Diaz
    Ferraris, Gustavo
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : S15 - S15
  • [48] Stereotactic ablative radiotherapy for oligometastatic non-small cell lung cancer
    Verma, Vivek
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2018, 10 (01) : 21 - 24
  • [49] Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic Gynecologic Malignancies: A Single Institution Experience
    Cuttino, L. W.
    Evans, J. E.
    Snyder, W. J.
    Ford, T. C.
    Egloff, S. Arnold
    Boardman, C. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E266 - E266
  • [50] Reirradiation With Stereotactic Ablative Radiotherapy In Recurrent Head And Neck Cancers
    Yigit, Ecem
    Yilmaz, Melek Tugce
    Kahvecioglu, Alper
    Yedekci, Fazli Yagiz
    Sari, Sezin Yuce
    Cengiz, Mustafa
    Ozyigit, Gokhan
    Gullu, Ibrahim
    Aksoy, Sercan
    Yazici, Gozde
    RADIOTHERAPY AND ONCOLOGY, 2024, 192 : S92 - S94
12345